| View |
2023-05-31-0184
|
BCG VACCINE
|
-
|
BR-572
|
0372G058
|
Packaging Lot (Box and Vial): 0372G058; (Diluent): 0702S4003
|
30-Nov-24
|
06 June 2023
|
| View |
2023-08-07-0273
|
BCG VACCINE
|
-
|
BR-572
|
0372G048
|
Packaging Lot (Box and Vial): 0372G048; (Diluent): 0703S1003
|
30-Nov-24
|
10 August 2023
|
| View |
LRV2024-02-23-0067
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) SOUTHERN HEMISPHERE 2024 STRAIN
|
FLUARIX TETRA
|
BR-1125
|
AFLBA787A
|
Packaging Lot (Box and Pre-filled Syringe): AFLBA787AB; (Needle 25G x 1"): 2210055; (Needle 25G x 5/8"): 2211023
|
30-Nov-24
|
27 February 2024
|
| View |
LRV2024-02-27-0070
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) SOUTHERN HEMISPHERE 2024 STRAIN
|
FLUARIX TETRA
|
BR-1125
|
AFLBA788A
|
Packaging Lot (Box and Pre-filled Syringe): AFLBA788AD; (Needle 25G x 1"): 2212041; (Needle 25G x 5/8"): 2212018
|
30-Nov-24
|
04 March 2024
|
| View |
LRV2024-06-20-0249
|
BACILLUS CALMETTE-GUERIN (BCG) VACCINE
|
-
|
BR-1363
|
576-10-22
|
Packaging Lot (Box and Ampoule): 576-10-22
|
30-Nov-24
|
26 June 2024
|
| View |
2023-04-12-0129
|
PURIFIED CHICK EMBRYO CELL CULTURE RABIES VACCINE
|
VAXIRAB N
|
BRP-071
|
RV20058
|
Packaging Lot: (Box and Vial): RV20058; (Diluent): AMY1001
|
30-Nov-25
|
18 April 2023
|
| View |
2023-05-31-0180
|
HUMAN RABIES IMMUNOGLOBULIN
|
BERIRAB P
|
BR-869
|
P100516667
|
Packaging Lot (Box and Pre-filled Syringe): P100516667; (Needle 21G x 1 1/2"): 1274628
|
30-Nov-25
|
02 June 2023
|
| View |
LRV2023-12-11-0385
|
DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B, POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED) [DTAP-IPV-HEPB-HIB]
|
HEXAXIM
|
BR-919
|
W3C55
|
Packaging Lot (Box): W3C551V; (PFS): W3C55; (Needle 25G x 5/8"): 2203032; (Needle 23G x 1"): 2201007
|
30-Nov-25
|
19 December 2023
|
| View |
LRV2024-01-10-0009
|
DIPTHERIA, TETANUS, PERTUSSIS (WHOLE CELL) HEPATITIS B (rDNA) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
|
COMBE FIVE
|
BR-1353
|
220105823A
|
Packaging Lot (Box and Vial): 220105823A
|
30-Nov-25
|
16 January 2024
|
| View |
LRV2024-01-24-0024
|
MEASLES VACCINE (LIVE, ATTENUATED)
|
M-VAC
|
BR-349
|
0013N001B
|
Packaging Lot (Box and Vial): 0013N001B; (Diluent): 0641S4008
|
30-Nov-25
|
29 January 2024
|
| View |
LRV2024-02-08-0053
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03323022
|
Packaging Lot (Box and Vial): A03323022
|
30-Nov-25
|
15 February 2024
|
| View |
LRV2024-02-08-0054
|
HUMAN NORMAL IMMUNOGLOBULIN (IGIV)
|
GAMMA I.V.
|
BR-636
|
A03323023
|
Packaging Lot (Box and Vial): A03323023
|
30-Nov-25
|
15 February 2024
|
| View |
LRV2024-03-21-0096
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23060
|
Packaging Lot (Box and Vial): 08AR23060
|
30-Nov-25
|
26 March 2024
|
| View |
LRV2024-03-21-0097
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23061
|
Packaging Lot (Box and Vial): 08AR23061
|
30-Nov-25
|
26 March 2024
|
| View |
LRV2024-03-21-0098
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23062
|
Packaging Lot (Box and Vial): 08AR23062
|
30-Nov-25
|
26 March 2024
|
| View |
LRV2024-03-21-0103
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23050
|
Packaging Lot (Box and Vial): 08AR23050
|
30-Nov-25
|
26 March 2024
|
| View |
LRV2024-03-21-0104
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23051
|
Packaging Lot (Box and Vial): 08AR23051
|
30-Nov-25
|
26 March 2024
|
| View |
LRV2024-03-26-0113
|
EQUINE ANTI-RABIES IMMUNOGLOBULIN
|
VINRAB
|
BRP-090
|
08AR23052
|
Packaging Lot (Box and Vial): 08AR23052
|
30-Nov-25
|
03 April 2024
|
| View |
LRV2024-04-05-0126
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06823031
|
Packaging Lot (Box and Vial): A06823031
|
30-Nov-25
|
11 April 2024
|
| View |
LRV2024-04-05-0127
|
ANTI-RABIES SERUM (EQUINE)
|
EQUIRAB
|
BR-676
|
A06823032
|
Packaging Lot (Box and Vial): A06823032
|
30-Nov-25
|
11 April 2024
|